20251218 180102 medical ganja sector. United States President Donald Trump has signed an executive order to foster out the reclassification of ganja under U.S. federal law. The order directs that ganja be moved from its current classification alongside hard drugs such as heroin and LSD to a Schedule III substance. That category includes drugs considered to have a moderate to low risk of dependence, such as Tylenol with codeine, ketamine and testosterone. President Trump says the aim is to expand research into medical ganja and CBD, allowing the U.S. Food and Drug Administration to more fully study AIDS medicinal benefits and risks. This reclassification order will make it far easier to conduct marijuana related medical research allowing us to study benefits, potential dangers and future
